Références

 

[1] Timoszuk M, Bielawska K, Skrzydlewska E. Evening Primrose (Oenothera biennis) Biological Activity Dependent on Chemical Composition. Antioxidants (Basel). 2018 Aug 14;7(8):108. Lien

[2] Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011 May;31(5):986-1000. Lien

[3] Kapoor R, Huang YS. Gamma linolenic acid: an antiinflammatory omega-6 fatty acid. Curr Pharm Biotechnol. 2006 Dec;7(6):531-4. Lien 

[4] Horrobin DF. The role of essential fatty acids and prostaglandins in the premenstrual syndrome. J Reprod Med. 1983 Jul;28(7):465-8. Lien

[5] Brush MG, Watson SJ, Horrobin DF, Manku MS. Abnormal essential fatty acid levels in plasma of women with premenstrual syndrome. Am J Obstet Gynecol. 1984 Oct 15;150(4):363-6. Lien

[6] Brown KM, Sharma S, Baker E, Hawkins W, van der Merwe M, Puppa MJ. Delta-6-desaturase (FADS2) inhibition and omega-3 fatty acids in skeletal muscle protein turnover. Biochem Biophys Rep. 2019 Mar 15;18:100622. Lien

[7] Ziboh VA, Fletcher MP. Dose-response effects of dietary gamma-linolenic acid-enriched oils on human polymorphonuclear-neutrophil biosynthesis of leukotriene B4. Am J Clin Nutr. 1992 Jan;55(1):39-45. Lien

[8] López-Martínez JC, Campra-Madrid P, Guil-Guerrero JL. Gamma-linolenic acid enrichment from Borago officinalis and Echium fastuosum seed oils and fatty acids by low temperature crystallization. J Biosci Bioeng. 2004;97(5):294-8. Lien

[9] Rocha Filho, E.A., Lima, J.C., Pinho Neto, J.S. et al. Essential fatty acids for premenstrual syndrome and their effect on prolactin and total cholesterol levels: a randomized, double blind, placebo-controlled study. Reprod Health 8, 2 (2011). Lien

[10] David DJ, Gardier AM. Les bases de pharmacologie fondamentale du système sérotoninergique : application à la réponse antidépressive [The pharmacological basis of the serotonin system: Application to antidepressant response]. Encephale. 2016 Jun;42(3):255-63. Lien

[11] Menkes DB, Coates DC, Fawcett JP. Acute tryptophan depletion aggravates premenstrual syndrome. J Affect Disord. 1994 Sep;32(1):37-44. Lien

[12] Hrboticky N, Leiter LA, Anderson GH. Menstrual cycle effects on the metabolism of tryptophan loads. Am J Clin Nutr. 1989 Jul;50(1):46-52. Lien

[13] Steinberg S, Annable L, Young SN, Liyanage N. A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria. Biol Psychiatry. 1999 Feb 1;45(3):313-20. Lien

[14] Freeman EW. Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder. CNS Drugs. 2004;18(7):453-68. Lien

[15] Kamal N, Mio Asni NS, Rozlan INA, Mohd Azmi MAH, Mazlan NW, Mediani A, Baharum SN, Latip J, Assaw S, Edrada-Ebel RA. Traditional Medicinal Uses, Phytochemistry, Biological Properties, and Health Applications of Vitex sp. Plants (Basel). 2022 Jul 26;11(15):1944. Lien

[16] Jarry H, Leonhardt S, Gorkow C, Wuttke W. In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Exp Clin Endocrinol. 1994;102(6):448-54. Lien

[17] Sliutz G, Speiser P, Schultz AM, Spona J, Zeillinger R. Agnus castus extracts inhibit prolactin secretion of rat pituitary cells. Horm Metab Res. 1993 May;25(5):253-5. Lien

[18] Meier B, Berger D, Hoberg E, Sticher O, Schaffner W. Pharmacological activities of Vitex agnus-castus extracts in vitro. Phytomedicine. 2000 Oct;7(5):373-81. Lien

[19] Wuttke W, Jarry H, Christoffel V, Spengler B, Seidlová-Wuttke D. Chaste tree (Vitex agnus-castus)--pharmacology and clinical indications. Phytomedicine. 2003 May;10(4):348-57. Lien

[20] Halbreich U, Ben-David M, Assael M, Bornstein R. Serum-prolatic in women with premenstrual syndrome. Lancet. 1976 Sep 25;2(7987):654-6. Lien

[21] Steiner M, Haskett RF, Carroll BJ, Hays SE, Rubin RT. Plasma prolactin and severe premenstrual tension. Psychoneuroendocrinology. 1984;9(1):29-35. Lien

[22] Tesch BJ. Herbs commonly used by women: an evidence-based review. Am J Obstet Gynecol. 2003 May;188(5 Suppl):S44-55. Lien

[23] van Die MD, Burger HG, Teede HJ, Bone KM. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med. 2013 May;79(7):562-75. Lien

[24] Webster DE, He Y, Chen SN, Pauli GF, Farnsworth NR, Wang ZJ. Opioidergic mechanisms underlying the actions of Vitex agnus-castus L. Biochem Pharmacol. 2011 Jan 1;81(1):170-7. Lien

[25] Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. BMJ. 2001 Jan 20;322(7279):134-7. Lien

[26] Cerqueira RO, Frey BN, Leclerc E, Brietzke E. Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Womens Ment Health. 2017 Dec;20(6):713-719. Lien

[27] Csupor D, Lantos T, Hegyi P, Benkő R, Viola R, Gyöngyi Z, Csécsei P, Tóth B, Vasas A, Márta K, Rostás I, Szentesi A, Matuz M. Vitex agnus-castus in premenstrual syndrome: A meta-analysis of double-blind randomised controlled trials. Complement Ther Med. 2019 Dec;47:102190. Lien

[28] Verkaik S, Kamperman AM, van Westrhenen R, Schulte PFJ. The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017 Aug;217(2):150-166. Lien

[29] Carmichael AR. Can Vitex Agnus Castus be Used for the Treatment of Mastalgia? What is the Current Evidence? Evid Based Complement Alternat Med. 2008 Sep;5(3):247-50. Lien

[30] Rafieian-Kopaei M, Movahedi M. Systematic Review of Premenstrual, Postmenstrual and Infertility Disorders of Vitex Agnus Castus. Electron Physician. 2017 Jan 25;9(1):3685-3689. Lien

[31] van Die MD, Burger HG, Teede HJ, Bone KM. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med. 2013 May;79(7):562-75. Lien

[32] Abenavoli L, Capasso R, Milic N, Capasso F. Milk thistle in liver diseases: past, present, future. Phytother Res. 2010 Oct;24(10):1423-32. Lien

[33] Federico A, Dallio M, Loguercio C. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years. Molecules. 2017 Jan 24;22(2):191. Lien

[34] Tsuchiya Y, Nakajima M, Yokoi T. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett. 2005 Sep 28;227(2):115-24. Lien

[35] Noviyanti NI, Gusriani, Ruqaiyah, Mappaware NA, Ahmad M. The effect of estrogen hormone on premenstrual syndrome (PMS) occurrences in teenage girls at Pesantren Darul Arqam Makassar. Gac Sanit. 2021;35 Suppl 2:S571-S575. Lien

[36] Kalhor, et al. 2019. Effect of Yarrow (Achillea millefolium L.) Extract on Premenstrual Syndrome in Female Students Living in Dormitory of Qazvin University of Medical Sciences Lien

[37] Jenabi E, Fereidoony B. Effect of Achillea Millefolium on Relief of Primary Dysmenorrhea: A Double-Blind Randomized Clinical Trial. J Pediatr Adolesc Gynecol. 2015 Oct;28(5):402-4. Lien

[38] Farzaneh Ebrahimi Varzaneh; Fatemeh Nahidi; Faraz Mojab; Mohamad Amin Pourhoseingholi; Zahra Panahi. "The effect of hydro alcoholic extract of AchilleaMillefolium capsule on duration and severity of primary dysmenorrhea pain". The Iranian Journal of Obstetrics, Gynecology and Infertility, 20, 3, 2017, 48-86. Lien

[39] Kozłowska A, Szostak-Wegierek D. Flavonoids--food sources and health benefits. Rocz Panstw Zakl Hig. 2014;65(2):79-85. Lien

[40] Hussain G, Rasul A, Anwar H, Aziz N, Razzaq A, Wei W, Ali M, Li J, Li X. Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders. Int J Biol Sci. 2018 Mar 9;14(3):341-357. Lien

[41] Moradi MT, Rafieian-Koupaei M, Imani-Rastabi R, Nasiri J, Shahrani M, Rabiei Z, Alibabaei Z. Antispasmodic effects of yarrow (Achillea millefolium L.) extract in the isolated ileum of rat. Afr J Tradit Complement Altern Med. 2013 Oct 3;10(6):499-503. Lien

[42] Lemmens-Gruber R, Marchart E, Rawnduzi P, Engel N, Benedek B, Kopp B. Investigation of the spasmolytic activity of the flavonoid fraction of Achillea millefolium s.l. on isolated guinea-pig ilea. Arzneimittelforschung. 2006;56(8):582-8. Lien

[43] T. Boroja, et al. The biological activities of roots and aerial parts of Alchemilla vulgaris L.South African Journal of Botany. Volume 116. 2018. Pages 175-18. Lien

[44] Reid R, Steel A, Wardle J, Adams J. Naturopathic Medicine for the Management of Endometriosis, Dysmenorrhea, and Menorrhagia: A Content Analysis. J Altern Complement Med. 2019 Feb;25(2):202-226. Lien

[45] Wenkui Li, et al. High-performance liquid chromatographic analysis of Black Cohosh (Cimicifuga racemosa) constituents with in-line evaporative light scattering and photodiode array detection. Analytica Chimica Acta, Volume 471, Issue 1, 2002, Pages 61-75. Lien

[46] Kruse SO, Löhning A, Pauli GF, Winterhoff H, Nahrstedt A. Fukiic and piscidic acid esters from the rhizome of Cimicifuga racemosa and the in vitro estrogenic activity of fukinolic acid. Planta Med. 1999 Dec;65(8):763-4. Lien

[47] He K, Pauli GF, Zheng B, Wang H, Bai N, Peng T, Roller M, Zheng Q. Cimicifuga species identification by high performance liquid chromatography-photodiode array/mass spectrometric/evaporative light scattering detection for quality control of black cohosh products. J Chromatogr A. 2006 Apr 21;1112(1-2):241-54. Lien

[48] Wuttke W, Seidlová-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas. 2003 Mar 14;44 Suppl 1:S67-77. Lien

[49] Seidlová-Wuttke D, Jarry H, Becker T, Christoffel V, Wuttke W. Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus. Maturitas. 2003 Mar 14;44 Suppl 1:S39-50. Lien

[50] Wuttke W, Gorkow C, Seidlová-Wuttke D. Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study. Menopause. 2006 Mar-Apr;13(2):185-96. Lien

[51] Nappi RE, Malavasi B, Brundu B, Facchinetti F. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol. 2005 Jan;20(1):30-5. Lien

[52] Szmyd M, Lloyd V, Hallman K, Aleck K, Mladenovik V, McKee C, Morse M, Bedgood T, Dinda S. The effects of black cohosh on the regulation of estrogen receptor (ERα) and progesterone receptor (PR) in breast cancer cells. Breast Cancer (Dove Med Press). 2018 Jan 18;10:1-11. Lien

[53] Mohapatra S, Iqubal A, Ansari MJ, Jan B, Zahiruddin S, Mirza MA, Ahmad S, Iqbal Z. Benefits of Black Cohosh (Cimicifuga racemosa) for Women Health: An Up-Close and In-Depth Review. Pharmaceuticals (Basel). 2022 Feb 23;15(3):278. Lien

[54] Aviva Romm, Bevin Clare, Jill E Stansbury, Linda Ryan, Ruth Trickey, Laurel Lee, Angela J. Hywood, CHAPTER 5 - Menstrual Wellness and Menstrual Problems, Editor(s): Aviva Romm, Mary L. Hardy, Simon Mills, Botanical Medicine for Women's Health, Churchill Livingstone, 2010. Lien

[55] Blumenthal M: The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicine, Boston, American Botanical Council, 1998. Lien

[56] Site internet du label Pycnogenol® 

[57] Schäfer A, Chovanová Z, Muchová J, Sumegová K, Liptáková A, Duracková Z, Högger P. Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol). Biomed Pharmacother. 2006 Jan;60(1):5-9. Lien

[58] Grimm T, Chovanová Z, Muchová J, Sumegová K, Liptáková A, Duracková Z, Högger P. Inhibition of NF-kappaB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol). J Inflamm (Lond). 2006 Jan 27;3:1. Lien

[59] Brochure issue du site internet Pycnogenol®

[60] Stover PJ, Field MS. Vitamin B-6. Adv Nutr. 2015 Jan 15;6(1):132-3. Lien

[61] Hvas AM, Juul S, Bech P, Nexø E. Vitamin B6 level is associated with symptoms of depression. Psychother Psychosom. 2004 Nov-Dec;73(6):340-3. Lien

[62] Wyatt KM, Dimmock PW, Jones PW, Shaughn O'Brien PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ. 1999 May 22;318(7195):1375-81. Lien

[63] Chocano-Bedoya PO, Manson JE, Hankinson SE, Willett WC, Johnson SR, Chasan-Taber L, Ronnenberg AG, Bigelow C, Bertone-Johnson ER. Dietary B vitamin intake and incident premenstrual syndrome. Am J Clin Nutr. 2011 May;93(5):1080-6. Lien